Narashino, Japan

Taichi Komoda

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Taichi Komoda: Innovator in Pharmaceutical Science

Introduction

Taichi Komoda is a notable inventor based in Narashino, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments. With a total of 3 patents to his name, Komoda's work has the potential to impact patient care positively.

Latest Patents

One of his latest patents involves a polymorphic form of sepiapterin. This patent discloses a crystalline form of sepiapterin, along with a method for preparing this crystalline form. It also includes pharmaceutical compositions containing the crystalline form and a method for treating patients with diseases associated with low intracellular BH4 levels or dysfunction in various BH4-dependent metabolic pathways. The treatment involves administering an effective amount of the crystalline form to the patient.

Career Highlights

Throughout his career, Taichi Komoda has worked with reputable companies such as PTC Therapeutics, Inc. and Shiratori Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Hiroshi Yoshino and Yuichi Shiro. Their collaborative efforts have likely enhanced the quality and impact of the projects they have worked on together.

Conclusion

Taichi Komoda's innovative work in the pharmaceutical field, particularly with his patents related to sepiapterin, showcases his dedication to improving patient outcomes. His contributions are a testament to the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…